Trial intelligence / Profile preview

Prospective trial of intravenous levetiracetam in patients with primary brain tumors undergoing biopsy or cytoreductive surgery

2007-005063-96Phase 4Completed

Sponsor
University Hospital Tübingen
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of levetiracetam in epilepsy and brain cancer, sponsored by University Hospital Tübingen. Primary endpoint: Feasibility. Started Oct 2007; status: completed.

02

Drugs

levetiracetam
03

Conditions

epilepsybrain cancer

Beyond the preview

Go deeper on 2007-005063-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005063-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call